View all news

    Janssen Submits Application to U.S. FDA Seeking Approval of STELARA® (USTEKINUMAB) for Treatment of Moderately to Severely Active Ulcerative Colitis

    12/20/2018
    Download(opens in new window)PDF 358 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com